Loading...

SUPRIYA Supriya Lifescience Ltd Major expansion or diversification plans Announcement

Spry

SPRY

Supriya Lifescience Ltd

(SUPRIYA)

2024 Announcement

Analyst / Institutional Inv...

Earnings Call Transcript

Unaudited Results

Earnings Call Audio

Unaudited Q2 results

Q2 FY26 Presentation

Unaudited quarterly results

Unaudited results

Earnings Call Notice

Board Meeting Notice

Compliance Certificate

WHO GMP Certification

Investor Meet Scheduled

AGM Notice Published

Annual Report Link

Annual General Meeting

Earnings Call Transcript

Earnings Call Recording

Newspaper Publication

Q1 FY26 Results

Investor Presentation

Policy Amendment

Earnings Call Scheduled

Clarification Notice

Investor Meet Scheduled

Investor Meetings

SEBI Compliance Certificate

GST Demand Notice

Dividend Taxation Update

Earnings Call Transcript

Secretarial Compliance Report

Earnings Call Recording

Financial Results Published

Record Growth Announcement

Investor Presentation

Auditor Appointment

Earnings Call Announcement

Investor Meeting

Compliance Certificate

Investor Meeting

Postal Ballot Notice

Investor Meetings

Key Management Details

Management Change

New Company Secretary

Investor Meeting Scheduled

Investor Meeting Scheduled

Investor Meeting

Investor Meeting

Investor Meeting Scheduled

Investor Meetings

Analyst Meetings

Director Retirements

Earnings Call Transcript

Financial Results Update

Earnings Call Recording

Financial Results Update

Q3 Earnings Surge

Investor Presentation

Resignation Notice

Key Managerial Update

Director Appointments

Earnings Call Notice

Compliance Certificate

Investor Meetings

Analyst Meet Reschedule

RTA Name Change

Clarification on News

Investor Meeting Scheduled

Investor Meeting

Investor Meetings

New Production Block

Investor Meetings

Global Expansion

Investor Meeting Scheduled

Investor Meetings

Investor Meetings

Investor Meeting Scheduled

Q2 FY25 Results

Financial Results Published

Strong Q2 Growth

Earnings Call Recording

Investor Presentation

Earnings Call Announcement

Compliance Certificate

Analyst Meetings

Investor Meetings Scheduled

Investor Meetings

Investor Meeting Notice

AGM Announcement

Investor Meeting

AGM Announcement

Investor Meetings

Investor Meeting Scheduled

Q1 Earnings Call

Earnings Call Audio

Strong Q1 Performance

Financial Results

Investor Presentation

Analyst Meeting Intimation

Investor Meetings

Investor Meeting

Publication of Postal Ballo...

Analyst Meeting

Analyst/Investor Meet

Earnings Call Transcript

Earnings Call Recording

Financial Results Release

Newspaper Publication

Changes in Management

Investor Presentation

Annual Compliance Report

Earnings Call Intimation

Monitoring Agency Report Su...

Analyst/Investor Meeting

Investor Meeting

Certificate Submission

Certificate Compliance

Compliance Certificate

Analyst Meeting

Analyst/Investor Meeting

Analyst Meeting

Investor Meeting

Conference Participation

Investor Meeting

Analyst/Investor Meeting

Conference Participation

Deviation in IPO Proceeds

Report Enclosed

Financial Results

Financial Results Update

Investor Presentation

Approval of Capital Expendi...

Certificate for Q4 2023

GMP Certification from ANVI...

Schedule of Analyst/Investo...

Investor Meetings

Participation in Conference

Deviation in Use of IPO Pro...

Monitoring Agency Report

Audio Recording

Financial Results Advertise...

Financial Results

Investor Presentation

Agreement with Kalinga Inst...

Collaboration for cancer de...

Certificate received for qu...

Investor Meetings

Meetings Intimation

Meeting Schedule

Meeting Schedule

Investor Meetings

Investor Meeting

Advertisement for AGM

Corporate Office

Meeting Schedule

Analyst/Investor Meeting

Earnings Call Transcript an...

Financial Statements

Financial Updates

Financial Statements

Financial Statements

Equity, Joint Ventures

Certificate under Regulatio...

Death of Promoter

Analyst/Investor Meeting

Postal Ballot Notice

Analyst / Investor Meet

Analyst/Investor Meetings

Earnings Call Transcript Su...

Management Changes

Earnings Call Recording

Financial Statements

Investor Presentation

Rights Offerings

Management Resignation

Audited Financial Results R...

Equity Investments

IPO Utilization Report

External Links:

Data:

Supriya Lifescience Ltd has received approval for a capital expenditure of Rs. 60 crores over the next 3 years for the development of a CDMO facility at their Ambernath site.

AI Assistant

Supriya Lifescience Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.